The compound hasn't been subjected on the rigorous clinical tests necessary for acceptance by regulatory bodies like the FDA, which suggests its security and performance in treating medical problems stay unproven.As exploration carries on, the knowledge of conolidine's total possible, particularly its effect on the CNS, will very likely evolve. The